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Abstract
Background: To determine safe surgical margins for soft tissue sarcoma, it is essential to perform a general evaluation
of the extent of tumor, responses to auxiliary therapy, and other factors preoperatively using multiple types of
diagnostic imaging. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is a
tool for diagnostic imaging that has recently spread rapidly in clinical use. At present, the roles played by FDG-PET/CT in
determination of margins for surgical resection of sarcoma are unclear. The present study was undertaken to explore
the roles of FDG-PET/CT in determination of surgical margins for soft tissue sarcoma and to examine whether PET can
serve as a standard means for setting the margins of surgical resection during reduced surgery.
Methods: The study involved 7 patients with sarcoma who underwent surgery in our department and in whom
evaluation with FDG-PET/CT was possible. Sarcoma was histologically rated as MFH in 6 cases and leiomyosarcoma
in 1 case. In all cases, sarcoma was superficial (T1a or T2a). The tumor border was defined by contrast-enhanced
MRI, and SUVs were measured at intervals of 1 cm over a 5-cm long area from the tumor border. Mapping of
viable tumor cells was carried out on whole-mount sections of resected tissue, and SUVs were compared with
histopathological findings.
Results: Preoperative maximum SUVs (SUV-max) of the tumor averaged 11.7 (range: 3.8-22.1). Mean SUV-max was
2.2 (range: 0.3-3.8) at 1 cm from the tumor border, 1.1 (0.85-1.47) at 2 cm, 0.83 (0.65-1.15) at 3 cm, 0.7 (0.42-0.95) at
4 cm, and 0.64 (0.45-0.82) at 5 cm. When resected tissue was mapped, tumor cells were absent in the areas where
SUV-max was below 1.0.
Conclusions: Our findings suggest that a safe surgical margin free of viable tumor cells can be ensured if the SUV
cut-off level is set at 1.0. FDG-PET/CT is promising as a diagnostic imaging technique for setting of safe minimal
margins for surgical resection of soft tissue sarcoma.
Background
In surgical treatment of soft tissue sarcoma, it is as a
rule necessary to remove the tumor in a reliable fashion
with surgical margins at which recurrence is unlikely.
With this principle, Enneking et al. [1] proposed exten-
sive resection based on the “compartment” concept.
Later, Kawaguchi et al. [2] proposed curative extensive
resection, adopting the concept of “barrier on the basis
of tumor-resistant tissue.” Guidelines for treatment of
varying stages of soft tissue sarcoma such as the
National Comprehensive Cancer Network (NCCN)
Guidelines are available, and techniques for soft tissue
sarcoma resection have been relatively well established.
In the past, contrast-enhanced MRI was often used as a
primary technique for determining surgical margins for
soft tissue sarcoma. It is essential to perform general
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therapy, and other factors preoperatively using multiple
diagnostic imaging techniques. In the present study, we
paid close attention to FDG-PET/CT, a tool for diagnos-
tic imaging the use of which has spread rapidly in recent
years. FDG-PET/CT has been shown to be useful in
grading soft tissue sarcoma and evaluating responses to
chemotherapy [3]. However, no report has been pub-
lished concerning the effectiveness of FDG-PET/CT in
determining surgical margins for soft tissue sarcoma. In
the field of radiation therapy, the use of FDG-PET in
combination with CT has been shown to enable efficient
planning of treatment, since FDG-PET enables more
accurate calculation of the actual extent of tumor than
macroscopic evaluation of target tumor volume with CT
or MRI [4,5]. This technique has been used effectively
in clinical practice. The present study was undertaken
to establish a new way of setting of surgical margins in
the direction free of biological barrier tissue [2,6,7] by
measurement of SUV at the tumor periphery.
Methods
The study involved 7 patients with subcutaneous soft
tissue sarcoma who underwent treatment in our depart-
ment between 2008 and 2009 and in whom evaluation
by FDG-PET/CT was possible. They included 3 males
and 4 females with a mean age of 70.4 years (range: 60-
79). The tumor was histologically rated as MFH in 6
cases and leiomyosarcoma in 1 case (Table 1). For these
cases, we determined tumor borders by using conven-
tional contrast-enhanced MRI, and resection was
planned to secure surgical margins between 3 and 5 cm
from tumor borders determined by contrast-enhanced
MRI. We selected 2 directions without biological bar-
riers from among sagittal, axial, and coronal directions
in tumor borders determined by preoperative contrast-
enhanced MRI, and we measured SUV values of soft tis-
sues that were indicated to be outside the tumor bor-
ders by contrast-enhanced MRI. SUV data by
preoperative FDG-PET/CT were analyzed using VISIO
KEOPSYS VIEWER (CODONICS: USA). In other
words, we determined that the regions of interest (ROI)
were at a distance of 5 cm and 1-cm interval from the
tumor borders by contrast-enhanced MRI, and mea-
sured their SUV-max value (Figure 1). After extensive
resection of the tumors, we performed mapping of neo-
plastic cells using whole area histological specimens of
the resected tissues and compared with the preoperative
SUV values (Figure 2).
Results
Preoperative SUV-max of the tumor averaged 11.7
( r a n g e :3 . 8 - 2 2 . 1 ) .M e a nS U V -max was 2.2 (range: 0.3-
3.8) at 1 cm from the tumor border, 1.1 (0.85-1.47) at 2
cm, 0.83 (0.65-1.15) at 3 cm, 0.7 (0.42-0.95) at 4 cm,
and 0.64 (0.45-0.82) at 5 cm (Table 2). When the
resected tissue was mapped, the regions not more than
1.0 in SUV-max were free of tumor cells (tumor positive
rate: 0%). The tumor positive rate was 25% for regions
with SUV-max between 1.0 and 2.0 and 80% for those
with SUV-max not less than 2.0 (Table 3). At present,
1Y to 2Y5M after the start of postoperative follow-up,
all patients are alive without recurrence (Table 1).
Discussion
In 1980, Enneking et al. [1] proposed a technique of
extensive resection by which dissection along the longi-
tudinal direction of muscle is performed from origin to
Table 1 Patient and tumour details
Sex/Age Histologic type Location SUV-max Follow-up period Recurrence Prognosis
Male/70 MFH Thigh 3.9 2y5M (-) DF
Male/73 MFH Chest 12.9 1y1M (-) AWD
Male/60 MFH Shoulder 10.5 1y1M (-) DF
Female/64 MFH Thigh 3.8 2y3M (-) DF
Female/77 MFH Forearm 13.8 2y2M (-) DF
Female/79 MFH Buttock 14.9 1y (-) DF
Female/70 Leiomyo Sarcoma Thigh 22.1 2y1M (-) DF
DF: disease free, AWD: alive with disease
Figure 1 The Setting of Regions of interest (ROIs) from the
tumor border. After the tumor border was defined by contrast-
enhanced MRI, regions of interest (ROIs) were set at intervals of 1
cm for the 5 cm long region from the tumor border in a direction
free of biological barrier. SUV data by preoperative FDG-PET/CT in
these regions were analyzed using VISIO KEOPSYS VIEWER
(CODONICS: USA). Measurement was performed in at least two
directions for each case. (Black arrow: tumor border defined by
contrast-enhanced MRI).
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formed in a compartment-wise fashion. Their technique,
however, featured problems such as excessively wide
resection and postoperative loss of function. In Japan,
Kawaguchi et al. [2] proposed in 1982 a technique for
curative extensive resection, adopting the concept of
barrier based on tumor resistance of fascia, periosteum,
cartilage tissue, and other tissues. Subsequently, data on
surgical margins for a very large number of cases were
analyzed to determine optimal methods of setting the
surgical margins depending on tumor type, degree of
histological malignancy, growth profile (invasive/nonin-
vasive), recurrence, need for additional surgery, pre-
sence/absence of preoperative therapy, and other
factors. On the basis of these analyses, extensive resec-
tion was defined as resection of the 1-4 cm area from
the tumor-reactive layer and curative extensive resection
as resection for 5 cm or more [6,7]. The guidelines pub-
lished in 2010 by the National Comprehensive Cancer
Network (NCCN) proposed methods of treatment for
varying stages of disease, and indicated that in case of
Stage 1 tumor resection with a margin not less than 1
cm, the local rate of recurrence is low and close follow-
up without active treatment suffices after resection
while in case with an eventual margin less than 1 cm,
addition of auxiliary radiotherapy is examined. In cases
of Stage II/III tumor resection should as a rule be exten-
sive (ensuring a margin of several centimeters free of
tumor cells in all directions) and combined with preo-
perative/postoperative adjuvant chemotherapy and
radiotherapy.
As indicated above, extensive resection with a safe
margin has been established. Furthermore, it has been
reported that adjuvant chemotherapy significantly
extends the length of time until local recurrence or dis-
tant metastasis of non-small round cell soft tissue sar-
coma and significantly improves the 10-year disease-free
survival rate [8]. Furthermore, outcome of treatment
was improved by radiation, which contributed to preser-
vation of affected limb function through tumor size
reduction when performed preoperatively and through
improvement of local control rate when performed post-
operatively [9,10]. However, large tumors, those invol-
ving the nerves/blood vessels, tumors resistant to
auxiliary therapy, and some other types of tumors still
require sufficiently extensive resection, including normal
tissue as well, accompanied by reconstruction-assisting
surgery using flaps, vascular prostheses, and other tech-
niques. These methods of treatment involve problems
such as high cost, long time of surgery, and long hospi-
tal stay [11,12]. It is therefore desirable to explore the
possibility of reducing surgical margins while observing
the principle of ensuring radical treatment of tumor.
Under these circumstances, we have recently begun to
pay close attention to FDG-PET/CT, which has recently
been reported to be useful in grading soft tissue sar-
coma and evaluating responses to chemotherapy [3]. In
the field of radiotherapy, the effectiveness of FDG-PET
as a means of determining thea r e ao fi r r a d i a t i o nf o r
various types of cancer has been increasingly evaluated.
When radiotherapy is planned, the area for irradiation, i.
e., the target volume, is first decided. The target volume
can be divided into gross tumor volume (GTV), clinical
target volume (CTV), internal target volume (ITV), and
planning target volume (PTV). When the target volume
is determined, assessment of lesion extent is most
important, making use not only of visual inspection and
palpation but also CT, MRI, FDG-PET, gastrointestinal
radiography, and other imaging methods. Some investi-
gators reported that more efficient treatment planning is
Figure 2 Mapping of viable tumor cells on the whole cut
section. Extensive resection of tumor was carried out with a margin
of 3-5 cm from the tumor periphery. Mapping of viable tumor cells
was carried out on whole sections of resected tissue (viable cells
mapped in red color).
Table 2 Preoperative SUV values
Distance from the tumor border SUV-max (range)
Tumor 11.7 (3.8 ~ 22.1)
0 ~ 1 cm 2.2 (0.3 ~ 3.8)
1 ~ 2 cm 1.1 (0.85 ~ 1.47)
2 ~ 3 cm 0.83 (0.65 ~ 1.15)
3 ~ 4 cm 0.7 (0.42 ~ 0.95)
4 ~ 5 cm 0.64 (0.45 ~ 0.82)
Table 3 The rates of viable tumor cells
SUV-max Tumor positive rate
< 1.0 0%
1.0 ~ 2.0 25%
> 2.0 80%
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CT, since FDG-PET enables more accurate calculation
of the actual extent of tumor compared to GTV based
on CT or MRI [4], while other investigators have
reported that GTV could be significantly reduced with
the use of FDG-PET compared to the use of CT scans
[13], thus demonstrating the usefulness of FDG-PET.
There is a report that because glucose consumption by
tumor stroma may be reduced by aerobic metabolism,
determination of the outline of the target cancer solely
on the basis of FDG during radiotherapy planning may
underestimate real tumor volume [14], indicating the
need for adequate evaluation of the validity of FDG in
treatment planning.
Although FDG-PET/CT is a powerful means of diag-
nostic imaging the use of which has spread rapidly in
recent years, its precise roles in setting of margins for
surgical resection of sarcoma have yet to be clearly
determined. In the present study, areas with SUV-max
less than 1.0 were free of viable tumor cells. This finding
suggests that safe surgical margins, ensuring the absence
of viable tumor cells, may be selected if the cut-off
SUV-max level is set at 1.0. Although the present study
was confined to cases of subcutaneous soft tissue sar-
coma, we plan to study the applicability of this techni-
que to evaluation of sarcoma around major nerves,
evaluation of bone invasion of sarcoma, and other types
of tissue. A limitation of this study is that the number
o fc a s e si sa ss m a l la s7 .T h i si sb e c a u s et h ei n c i d e n c e
of sarcoma is overwhelmingly low compared with that
of cancer; therefore, it was difficult to design a large-
scale study since our study was limited to subcutaneous
sarcomas. In the present study, SUV-max can vary
greatly among tumors of the same type. It is desirable
to examine a larger number of cases to determine
whether the cut-off SUV-max level can be uniformly set
at 1.0 in all cases including those with tumor the center
of which has a low SUV-max. Hence, at the present
stage, our study results may be presented as a case
report. In the future, we need to collect a variety of
cases from multi-institutions a sw e l la sas i n g l ei n s t i t u -
tion and further accumulate reliable data. Furthermore,
in cases in which the body position during FDG-PET/
CT differs from that during operation, the surgeon
needs to take into account possible discrepancies
between SUV data and actual tumor location. In recent
years, FLT-PET using fluorothymidine (FLT) as a tracer
has been performed to differentiate between inflamma-
tory and tumor lesions. Thymidine is one of the ele-
ments present in the DNA, and its incorporation into
cells is known as an indicator for cellular proliferation.
FLT is an analog of thymidine. FLT is phosphorylated
by a thymidine salvage pathway; however, it is not
incorporated into nuclei. Malignant tumors show rapid
cell proliferation and enhanced nucleic acid synthesis.
Because the accumulation rate of FLT in inflammatory
sites is considered to be lower than that of FDG, FLT
might be more useful for determining the surgical mar-
gins of tumors.
Conclusions
Our findings suggest that a safe surgical margin free
of viable tumor cells can be ensured if the SUV cut-
o f fl e v e li ss e ta t1 . 0 .F D G - P E T / C Ti sp r o m i s i n ga sa
diagnostic imaging technique for setting of safe mini-
mal margins for surgical resection of soft tissue
sarcoma.
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